1. Driving business development for WuXi Biologics across the Scandinavian region by building strategic partnerships with biotech, pharma, and academic institutions. Supporting clients with tailored CRO solution from antibody discovery, development to preclinical studies. 2. Helping life science innovators in Scandinavia accelerate their biologics pipelines. Focusing on establishing long-term collaborations, aligning scientific expertise with client needs, and delivering flexible end-to-end CRO/CRDMO services to reduce risks and shorten timelines. 3.

(5 years 2 months) 1. Anti-cancer drug discovery and development targeting cellular antioxidant systems. 2. Investigating the synergistic effects of chemotherapies and immunotherapies across various cancer models. 3. Exploring the function of key proteins in cancer cell signaling and metabolic disorders. 4. Establishing and advancing cutting-edge imaging technologies for diverse research projects.